Skip to Content Facebook Feature Image

Amai Proteins succesfully completed world's first human clinical trial on effects of sweet proteins, with sweelin®

Business

Amai Proteins succesfully completed world's first human clinical trial on effects of sweet proteins, with sweelin®
Business

Business

Amai Proteins succesfully completed world's first human clinical trial on effects of sweet proteins, with sweelin®

2024-12-17 09:00 Last Updated At:09:15

REHOVOT, Israel, Dec. 17, 2024 /PRNewswire/ -- Amai Proteins, a scale-up designer of novel proteins that answer the needs of consumers and industry, has succesfullly completed world's first double-blind, random clinical trial on the effects of their proprietary hyper-sweet protein, sweelin®, on blood glucose and insulin levels in humans.

The study demonstrated that sweelin® neither raises blood glucose nor blood insulin levels in healthy adults even after consuming an amount equivalent to the sweetness of 75 grams of sugar (in the form of glucose).

Although not required by regulatory authorities, Amai Proteins decided to conduct this study to boost consumer and market confidence in the safety and health profile of sweelin®. The study provides validated evidence of the beneficial effects of sweelin® on consumer's health. sweelin® can help consumers globally who are trying to reduce added sugars in their diet but don't want to compromise on taste or health.

The study was conducted at the Phase 1 Clinical Research Center (CRC) of Tel Aviv Sourasky Medical Center, under strict Good Clinical Practice (GCP) standards. Twenty eligible healthy volunteers completed the screening process and participated in the study.

All participants made three visits to the medical center. During each visit, the participants consumed one of three test beverages sweetened by either sweelin®, glucose, or stevia in a crossover double-blind, randomized controlled manner. All beverages were matched for sweetness intensity, with their dosage aligned to the sweetness equivalent of 75 grams of glucose, as used in a standard Oral Glucose Tolerance Test (OGTT). The study monitored the participants' response to the test beverages for 120 minutes after consumption, measuring postprandial blood glucose and insulin levels.

All the participants successfully completed the study with no test-item-related adverse events, and no dropouts.

For the first time, this study by Amai proteins confirmed that a high dose of sweelin®, which can be labelled as 'serendipity berry sweet protein', does not impact blood glucose or insulin levels in healthy individuals.

About Amai Proteins

Amai Proteins develops novel proteins which answer the needs of consumers and industry. Our first product, sweelin®, is a calorie-free sweet protein designed to significantly replace sugar and sugar alternatives in a wide variety of food & beverages including soft drinks, fruit juice, dairy products, sauces, spreads, dressings, snacks, peanut butter, and much more. Our solutions are inspired by nature and built with biology through a natural fermentation process. With our Pro3 platform, Amai Proteins aims to create future breakthroughs in the world of meat, plant and milk proteins.

www.amaiproteins.com or visit our official LinkedIn and YouTube channels.

For more on sweelin®, visit sweelin.com 

For more information:

Dr. Ilan Samish, Founder & CEO, Amai Proteins
press@amaiproteins.com

Video - https://www.youtube.com/watch?v=nFx1yM-8qL0
Video - https://youtu.be/8p58pIhJi-I

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Amai Proteins succesfully completed world's first human clinical trial on effects of sweet proteins, with sweelin®

Amai Proteins succesfully completed world's first human clinical trial on effects of sweet proteins, with sweelin®

Next Article

Omi wraps up 2024 dating trends

2024-12-17 08:00 Last Updated At:08:15

SINGAPORE, Dec. 17, 2024 /PRNewswire/ -- Drawing insights from over 25,000 users aged 18 to 35 across key markets, Omi observes a shift in 2024 dating trends towards autonomous and intentional connections. This includes women taking the lead in dating dynamics and the integration of AI for safer dating experiences.

Women Leading the Way

Women are confidently reshaping the dating narrative, with 53% initiating conversations—a significant departure from tradition. Female-initiated chats last longer and are 26% more likely to result in successful match, such as ongoing conversations or in-person plans. This marks a pivotal move toward gender equality, highlighting the power of authenticity and boldness in forming connections.

Icebreakers Matter More Than Ever

Gone are the days of uninspired openers like "Hey". Personalized, creative icebreakers now take center stage, with openers especially those referencing to shared interests through Omi's Interest Tag. Paying attention to the other person's profile proves far more engaging, with thoughtful openers making conversations 31% more likely to develop into meaningful exchanges.

Back to Classic First Date

Singles are continuing to pritotize thoughtful first-date experience. Last year, economic challenges saw Gen Z redefining first-date norms, with grocery shopping emerging as a fun, budget-friendly alternative to traditional venues. This year, Omi's findings reveal a shift back to more classic preferences, with 42% favoring cafes for their relaxed atmosphere, 28% opting for outdoor activities, and 19% enjoying casual dining.

Prioritizing Genuine Connections

Gen Z daters are open to being "tagged" by shared interests rather than external attributes. In fact, 57% of Omi's Gen Z users fill out more than five tags, with a 21% higher preference among women. The algorithm behind Omi's interest tags analyzes hidden connections to bring like-minded individuals together. As Daniel Fok, Omi's Product Director, reveals: "With over three common interest tags, users can achieve an almost perfect match rate of nearly 100%."

AI in the Dating House

As the 2020s usher in a period of rapid AI development, 90% of users are open to using AI features to enhance their profiles or select photos. However, 62% express concerns about their photos and personal information being misused. Omi's tech team employs AI anti-spam strategies, locking and removing over 1500 high-risk accounts daily. Coupled with a 24-hour moderation team, we keep fraudulent activities to a mere 0.001%. Additionally, Omi has signed anti-fraud white papers with police in Taiwan, Malaysia, and other regions, pledging full cooperation in investigations to protect victims' rights.

About Omi App

Omi is a social network that allows you to date pleasantly and safely. No matter you are looking for true love, a date, a travel buddy, a board game companion, or just a chit chat, you can always come to Omi to find your group.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Omi wraps up 2024 dating trends

Omi wraps up 2024 dating trends

Recommended Articles